UCLH

We are delighted to announce that Tessa Green CBE will join us as our new chair on 1 October 2026. Tessa will take up the position when our current chair, Baroness Julia Neuberger, completes her term after more than seven years in the role. Tessa brings significant leadership experience in healthcare, having previously served as chair of The Royal Marsden NHS Foundation Trust and Moorfields Eye Hospital NHS Foundation Trust. Tessa originally qualified as a barrister and has extensive experience in the charitable and commercial sectors. "I am honoured to be stepping into the role of chair of UCLH,” said Tessa. “This is an exciting period as UCLH prepares to launch a refreshed strategy, and it’s a pivotal time for the NHS as it implements the ambitions of the government’s 10-Year Plan. “I’m looking forward to working with colleagues across the organisation who do an incredible job of caring for more than one million patients a year and to collaborating with partners to improve the health of the wider population that UCLH serves.” UCLH chief executive David Probert said: “I am delighted to welcome Tessa as our new chair. She is passionate about the NHS and cares deeply about improving patient care. She also brings great energy, insight and innovative thinking to all that she does. These attributes, along with Tessa’s previous leadership of world class specialist hospitals will be invaluable to UCLH, as we embrace the opportunities and tackle the challenges ahead. I’m very much looking forward to working with her to shape an exciting future for UCLH.” Read more by visiting our latest news via our linktree in bio.

“During my time as a paediatric nurse, I’ve learned something that stays with me every day: children don’t care about your title, your experience, or your accomplishments. What matters to them is to feel safe, seen and understood. They need to know they can trust you, especially when they’re at their most vulnerable. That emotional comfort can positively influence how they respond to treatment and even how quickly they recover.” On International Nurses' Day, Ruby Frances Caldito (pictured), deputy sister, Paediatric ENT Outpatients Department shares her beautiful artwork, ‘Healing Begins with Kindness’, inspired by this year's theme, ‘Our Nurses. Our Future. Empowered Nurses Save Lives’. Thank you for your dedication to our patients and to each other. #oneteam💙 #internationalnursesday #IND2026 #nhs #healthcare #nurses

We are proud to be one of Europe’s leading centres for CAR T-cell therapy. CAR T-cell therapy is a cutting-edge treatment for certain blood cancers, offering new hope to patients whose illness hasn’t responded to standard treatments. We support patients and families at every stage, from referral and assessment to recovery and follow-up. ▶️ Learn more about the innovative treatment and care by watching our video via our linktree in bio. #nhs #healthcare #cancer #cartcell #haematology #uclh

UCLH patient Tim Wiberg, 61, of Sheffield, is the third patient with amyloidosis in Europe to receive CAR T-cell therapy under clinical trial conditions in a bid to find whether immunotherapy may hold some answers for this patient group. Tim was diagnosed two years ago but is still coming to terms with his condition. A diagnosis like this takes time to sink in. I’m not sure I’ve fully come to terms with it even now. It’s a life-changing disease.” After six months of weekly chemotherapy only managed to produce a partial response, he was offered the chance to take part in ALARIC. “The standard treatment had only gone so far, and it felt as though the options were beginning to narrow,” he said. “This trial offered something different — a new and innovative way of tackling the disease. Yes, there are risks, but there is also hope. Being offered a place made me feel far more positive. “It feels like a genuine opportunity, not just for me, but for others who may face this diagnosis in the future. If my experience can help move things forward, then it feels worth sharing.” Tim received his CAR T cells on 2 March and is currently recovering at home. Of the experience, he said: “I was in hospital for two weeks and I can honestly say the hardest part was being woken up every few hours for nurses to get my vitals. But they were absolutely wonderful, I cannot fault the care. “Amyloidosis is mainly measured by the prevalence of some bad proteins called lambda light chains. At my worst, before any treatment, I had around 200. And after the infusion, they are now almost immeasurable. So that really says it all.” If successful, CAR T-cell therapy could offer patients a single treatment with a high and lasting response rate. By suppressing the abnormal cells at their source, it may also give damaged organs a better chance to recover. Read the full story by visiting our latest news via our linktree in bio.

Today and every day, we celebrate midwives for the compassion, expertise and dedication they show in supporting people through pregnancy, birth and beyond at one of the most important times in their lives. Lyndsey Smith, director of midwifery said: “On this #InternationalDayoftheMidwife, we would like to extend our heartfelt thanks and admiration to midwives everywhere. “This year’s theme – ‘One Million More Midwives’ – is a powerful global call to recognise the critical importance of the midwifery profession and the need to strengthen and grow this essential workforce.” #IDM2026💙

Even as we go into spring, COVID-19 can be very dangerous for people with a weakened immune system. Book now to top up your protection at /book-covid or visit our walk-in vaccine clinic at the University College Hospital Grafton Way Building.

Looking forward to seeing the Healing Voices Choir as they join @sydniechristmas on @bgt this Saturday at 9pm. The Healing Voices Choir is supported by @uclhcharity and @greatormondst Charity [Image from December 2025 at an event]

Even as we go into spring, COVID-19 can be very dangerous for older adults. Walk-ins to our vaccine clinic at University College Hospital Grafton Way Building are welcome or you can book in advance at /book-covid #covid19

📖 The latest UCLH Magazine is out now! Pick up a copy at any of our hospital sites, or read it online via our linktree in bio.

Discover the groundbreaking world of CAR T-cell therapy at UCLH, one of Europe's largest #haematology services. Our new video provides a comprehensive walkthrough of the journey for patients undergoing this treatment, from the initial collection of immune cells to recovery and long-term care. Watch the full video via our linktree in bio. #nhs #healthcare #cancer

Some patients with bowel cancer treated with immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of follow-up, according to new results from the NEOPRISM-CRC clinical trial led by UCL and UCLH. The latest findings, presented at the American Association for Cancer Research (AACR) Annual Meeting 2026 yesterday, build on earlier results showing that nine weeks of pre-operative immunotherapy using the drug pembrolizumab led to major tumour shrinkage in patients with stage two or three bowel cancer. Initial results indicated that 59% of patients had no signs of disease after treatment with pembrolizumab and their planned bowel cancer operation. Now 33 months later, none of the treated patients have experienced a return of their cancer. This includes those who had no signs of cancer after treatment and those who still had small amounts remaining, which did not grow or spread during follow-up. Read the full story by visiting our latest news via our linktree in bio.

We're creating new opportunities so young people from disadvantaged backgrounds can pursue their dreams of a career in the NHS. @wesstreeting met medical students @uclh to find out more about the barriers they've overcome.